Nazal Liquid
FDA Label NDC 49873-057

14 label sections · Submitted to the FDA by Sato Pharmaceutical Co., Ltd. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Sato Pharmaceutical Co., Ltd. for the product Nazal (NDC 49873-057). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, warnings, otc - do not use, otc - ask doctor, otc - when using, otc - stop use, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

Active ingredients  
Naphazoline hydrochloride 0.05%

Otc - Purpose

Purpose    Nasal decongestant

Indications & Usage

Uses for the temporary relief of nasal congestion due to the common cold, hay fever, or associated with sinusitis

Warnings

Warnings
For external use only

Dosage & Administration

Directions
Adults and children 12 years of age and older - 1 or 2 sprays in each nostril not more often than every 6 hours
Children under 12 years of age -  do not give unless directed by a doctor

Other Safety Information

Other information  
■container is filled to proper level for best spray action

Inactive Ingredient

Inactive ingredients
benzalkonium chloride, citric acid, dibasic potassium phosphate, fragrance, monobasic potassium phosphate, simethicone, sodium chloride, water

Package Label.Principal Display Panel

nazalcart.jpg

Carton (Nazalcart)

Carton (Nazalcart)

* Please review the disclaimer below.